As plasma membrane-localized SK can promote oncogenesis [6], we hypothesized that a loss of SK2 from the plasma membrane, and a consequent decrease in the rate of extracellular S1P formation, resulting from re-expression of IC1 may reduce the oncogenic potential of these GBM cells. Here, SPHK2 is linked to glioblastoma.